Cell and gene therapies (C>s) have emerged as revolutionary treatments, particularly for rare diseases with limited treatment options. The rapid growth in demand for these personalized medicines has posed significant challenges for the industry, particularly in maintaining product consistency,
Mereo BioPharma Group, a dynamic player in the biopharmaceutical sector specializing in oncology and rare disease therapeutics, is undergoing notable shifts in institutional investments. Investors closely monitoring Mereo BioPharma Group will find a mixed landscape marked by both reductions and
In a significant step towards fostering environmental responsibility in the pharmaceutical sector, Tower Cold Chain has launched a new sustainability hub designed to help pharmaceutical manufacturers improve their environmental, social, and governance (ESG) practices. This initiative highlights the
Afton Scientific is making headlines with its substantial investment of over $200 million to expand its biopharmaceutical manufacturing facility in Albemarle County, Virginia. This significant expansion not only highlights the company's commitment to growth but also underscores the robust health of
The biotech and pharmaceutical industries are highly dynamic fields reliant on constant innovation, robust networking, and strategic investor relations. Professionals in these sectors must attend top biopharma conferences to keep pace with the latest advancements, regulatory trends, and emerging
There is no question that obesity is one of the most common healthcare problems plaguing the modern world. According to the National Health and Nutrition Examination Survey (NHANES), 42.4% of Americans suffer from obesity, while 30.7% are on their way to becoming obese. Moreover, approximately 1 in
The U.S. landscape of biotechnology and pharmaceutical research is marked by clusters of innovation, investment, and scientific output. For 2024, several regions stand out due to their exceptional contributions to the biopharma sectors, from Boston’s academic might to San Diego’s venture capital
In a series of unexpected events, a seemingly minor code violation involving a green garden hose led to the discovery and subsequent shutdown of an unlicensed lab in Reedley, California. The facility, operated by Prestige Biotech and Universal Meditech, revealed a dangerous assortment of hazardous
PCI Pharma Services has made a monumental $365 million investment to enhance its capabilities in the assembly and packaging of sophisticated drug-device combination products, particularly those involving injectable formats. This global Contract Development and Manufacturing Organization (CDMO) aims
Europe's rich heritage in pharmaceutical innovation has significantly shaped the global landscape. Yet, recent decades have seen this continent cede its leading position to the U.S. and witness emerging markets like China and India surge ahead. The question now is whether Europe can chart a path
